Comtan (entacapone), a new COMT inhibitor for advanced Parkinson's disease

Novartis is now marketing Comtan (entacapone), a new COMT inhibitor for advanced Parkinson's disease. ...

Exclusive Subscriber Content

  • Best in class medication learning
  • Concise recommendations
  • Hundreds of practical resources

Subscribe Now Learn More

Login to access this content.

Login